Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Enovix (ENVX) Other financing activities (2023 - 2025)

Enovix's Other financing activities history spans 2 years, with the latest figure at $1.3 million for Q4 2025.

For Q4 2025, Other financing activities changed N/A year-over-year to $1.3 million; the TTM value through Dec 2025 reached $12.7 million, up 1803.15%, while the annual FY2025 figure was $11.2 million, N/A changed from the prior year.
Other financing activities reached $1.3 million in Q4 2025 per ENVX's latest filing, down from $11.4 million in the prior quarter.
In the past five years, Other financing activities ranged from a high of $11.4 million in Q3 2025 to a low of -$90000.0 in Q1 2023.